{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:50:09Z","timestamp":1789617009810,"version":"build-2803163510"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["1R21AR080352-01"],"award-info":[{"award-number":["1R21AR080352-01"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Arthrofibrosis is defined as the excessive accumulation of connective tissue in and around joints, which interferes with the range of motion required for activities of daily living. Although joint stiffness can be restored by surgical interventions such as adhesion lysis, arthroscopic debridement, and capsular release, arthrofibrosis tends to redevelop in the months following the surgery. Thus, there is a critical and urgent need to develop a non-invasive, pharmacological therapy to prevent or resolve arthrofibrosis. A subclass of small extracellular vesicles called exosomes convey bioactive regulators like micro ribonucleic acids (miRNAs\/miRs), which can function as anti- and pro-fibrotic agents. Currently, there is no research on miRNA-based therapeutic potentials for treating arthrofibrosis. Previous research and clinical observations on fibrosis across organ systems suggest that there are commonalities in pathogenic mechanisms that can be targeted in arthrofibrosis therapy. In this study, we collated and critically analyzed the existing literature on exosomal miRNAs in organ fibrosis to discover potential candidates for diagnosing, preventing, and\/or treating arthrofibrosis. Fifty-six articles were finally selected and categorized by anti- and pro-fibrotic candidates of miRNAs. Notably, let-7, miR-26, miR-29, miR-146, miR-148\/-152, miR-214, miR-223, and miR-21 emerged as prominent candidates that should be investigated further for effectiveness in arthrofibrosis therapy.<\/jats:p>","DOI":"10.1186\/s12967-025-06810-x","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T17:19:38Z","timestamp":1752772778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Systematic review of extracellular vesicle-derived microRNAs involved in organ fibrosis: implications for arthrofibrosis therapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Venkateswaran","family":"Ganesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliasger K.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungsup","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0383-3756","authenticated-orcid":false,"given":"Dongrim","family":"Seol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"6810_CR1","doi-asserted-by":"publisher","first-page":"12183","DOI":"10.1073\/pnas.1900355116","volume":"116","author":"WA Blessing","year":"2019","unstructured":"Blessing WA, et al. Intraarticular injection of relaxin-2 alleviates shoulder arthrofibrosis. Proc Natl Acad Sci. 2019;116:12183\u201392.","journal-title":"Proc Natl Acad Sci"},{"key":"6810_CR2","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1007\/s00167-017-4482-1","volume":"25","author":"S Ekhtiari","year":"2017","unstructured":"Ekhtiari S, et al. Arthrofibrosis after ACL reconstruction is best treated in a step-wise approach with early recognition and intervention: a systematic review. Knee Surg Sports Traumatol Arthrosc. 2017;25:3929\u201337. https:\/\/doi.org\/10.1007\/s00167-017-4482-1.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"6810_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/JSA.0000000000000324","volume":"30","author":"DR Lee","year":"2022","unstructured":"Lee DR, et al. Arthrofibrosis nightmares: prevention and management strategies. Sports Med Arthrosc Rev. 2022;30:29\u201341. https:\/\/doi.org\/10.1097\/JSA.0000000000000324.","journal-title":"Sports Med Arthrosc Rev"},{"key":"6810_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/1758573216676786","volume":"9","author":"HV Le","year":"2017","unstructured":"Le HV, Lee SJ, Nazarian A, Rodriguez EK. Adhesive capsulitis of the shoulder: review of pathophysiology and current clinical treatments. Shoulder Elb. 2017;9:75\u201384. https:\/\/doi.org\/10.1177\/1758573216676786.","journal-title":"Shoulder Elb"},{"key":"6810_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41413-019-0047-x","volume":"7","author":"KM Usher","year":"2019","unstructured":"Usher KM, et al. Pathological mechanisms and therapeutic outlooks for arthrofibrosis. Bone Res. 2019;7:9. https:\/\/doi.org\/10.1038\/s41413-019-0047-x.","journal-title":"Bone Res"},{"key":"6810_CR6","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","volume":"170","author":"B Hinz","year":"2007","unstructured":"Hinz B, et al. The myofibroblast: one function, multiple origins. Am J Pathol. 2007;170:1807\u201316. https:\/\/doi.org\/10.2353\/ajpath.2007.070112.","journal-title":"Am J Pathol"},{"key":"6810_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/jor.24499","volume":"38","author":"K Atluri","year":"2020","unstructured":"Atluri K, et al. Sulfasalazine resolves joint stiffness in a rabbit model of arthrofibrosis. J Orthop Res. 2020;38:629\u201338. https:\/\/doi.org\/10.1002\/jor.24499.","journal-title":"J Orthop Res"},{"key":"6810_CR8","doi-asserted-by":"publisher","first-page":"22627","DOI":"10.1038\/s41598-022-22175-3","volume":"12","author":"AK Limberg","year":"2022","unstructured":"Limberg AK, et al. Immune cell populations differ in patients undergoing revision total knee arthroplasty for arthrofibrosis. Sci Rep. 2022;12:22627. https:\/\/doi.org\/10.1038\/s41598-022-22175-3.","journal-title":"Sci Rep"},{"key":"6810_CR9","doi-asserted-by":"publisher","unstructured":"Antar SA, Ashour NA, Marawan ME, Al-Karmalawy AA, Fibrosis. Types, effects, markers, mechanisms for disease progression, and its relation with oxidative stress, immunity, and inflammation. Int J Mol Sci. 2023;24. https:\/\/doi.org\/10.3390\/ijms24044004.","DOI":"10.3390\/ijms24044004"},{"key":"6810_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphar.2014.00123","volume":"5","author":"RT Kendall","year":"2014","unstructured":"Kendall RT, Feghali-Bostwick CA. Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol. 2014;5:123. https:\/\/doi.org\/10.3389\/fphar.2014.00123.","journal-title":"Front Pharmacol"},{"key":"6810_CR11","doi-asserted-by":"publisher","first-page":"13556","DOI":"10.1039\/d2cc04825f","volume":"58","author":"E Beaven","year":"2022","unstructured":"Beaven E, Kumar R, Bhatt HN, Esquivel SV, Nurunnabi M. Myofibroblast specific targeting approaches to improve fibrosis treatment. Chem Commun (Camb). 2022;58:13556\u201371. https:\/\/doi.org\/10.1039\/d2cc04825f.","journal-title":"Chem Commun (Camb)"},{"key":"6810_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.addr.2017.07.010","volume":"121","author":"S Yazdani","year":"2017","unstructured":"Yazdani S, Bansal R, Prakash J. Drug targeting to myofibroblasts: implications for fibrosis and cancer. Adv Drug Deliv Rev. 2017;121:101\u201316. https:\/\/doi.org\/10.1016\/j.addr.2017.07.010.","journal-title":"Adv Drug Deliv Rev"},{"key":"6810_CR13","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1002\/jcp.29302","volume":"235","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Hou Q, Li M, Fu X. Molecular mechanism of myofibroblast formation and strategies for clinical drugs treatments in hypertrophic scars. J Cell Physiol. 2020;235:4109\u201319. https:\/\/doi.org\/10.1002\/jcp.29302.","journal-title":"J Cell Physiol"},{"key":"6810_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","volume":"19","author":"S Gurung","year":"2021","unstructured":"Gurung S, Perocheau D, Touramanidou L, Baruteau J. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal. 2021;19:47. https:\/\/doi.org\/10.1186\/s12964-021-00730-1.","journal-title":"Cell Commun Signal"},{"key":"6810_CR15","doi-asserted-by":"publisher","first-page":"115087","DOI":"10.1016\/j.biopha.2023.115087","volume":"165","author":"J Li","year":"2023","unstructured":"Li J, Zhang Y, Dong PY, Yang GM, Gurunathan S. A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy. Biomed Pharmacother. 2023;165:115087. https:\/\/doi.org\/10.1016\/j.biopha.2023.115087.","journal-title":"Biomed Pharmacother"},{"key":"6810_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13578-019-0282-2","volume":"9","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019;9:19. https:\/\/doi.org\/10.1186\/s13578-019-0282-2.","journal-title":"Cell Biosci"},{"key":"6810_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semcdb.2021.03.019","volume":"124","author":"RA Naqvi","year":"2022","unstructured":"Naqvi RA, Gupta M, George A, Naqvi A. R. MicroRNAs in shaping the resolution phase of inflammation. Semin Cell Dev Biol. 2022;124:48\u201362. https:\/\/doi.org\/10.1016\/j.semcdb.2021.03.019.","journal-title":"Semin Cell Dev Biol"},{"key":"6810_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3978\/j.issn.2304-3881.2015.01.05","volume":"4","author":"S Roy","year":"2015","unstructured":"Roy S, Benz F, Luedde T, Roderburg C. The role of MiRNAs in the regulation of inflammatory processes during hepatofibrogenesis. Hepatobiliary Surg Nutr. 2015;4:24\u201333. https:\/\/doi.org\/10.3978\/j.issn.2304-3881.2015.01.05.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"6810_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ceb.2020.08.015","volume":"67","author":"H Galagali","year":"2020","unstructured":"Galagali H, Kim JK. The multifaceted roles of MicroRNAs in differentiation. Curr Opin Cell Biol. 2020;67:118\u201340. https:\/\/doi.org\/10.1016\/j.ceb.2020.08.015.","journal-title":"Curr Opin Cell Biol"},{"key":"6810_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.matbio.2012.11.003","volume":"32","author":"ZJ Rutnam","year":"2013","unstructured":"Rutnam ZJ, Wight TN, Yang BB. MiRNAs regulate expression and function of extracellular matrix molecules. Matrix Biol. 2013;32:74\u201385. https:\/\/doi.org\/10.1016\/j.matbio.2012.11.003.","journal-title":"Matrix Biol"},{"key":"6810_CR21","doi-asserted-by":"publisher","first-page":"8474","DOI":"10.18632\/oncotarget.3523","volume":"6","author":"Z Su","year":"2015","unstructured":"Su Z, Yang Z, Xu Y, Chen Y, Yu Q. MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget. 2015;6:8474\u201390. https:\/\/doi.org\/10.18632\/oncotarget.3523.","journal-title":"Oncotarget"},{"key":"6810_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215\u201333. https:\/\/doi.org\/10.1016\/j.cell.2009.01.002.","journal-title":"Cell"},{"key":"6810_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of MicroRNAs. Genome Res. 2009;19:92\u2013105. https:\/\/doi.org\/10.1101\/gr.082701.108.","journal-title":"Genome Res"},{"key":"6810_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1261\/rna.068692.118","volume":"25","author":"G Michlewski","year":"2019","unstructured":"Michlewski G, Caceres JF. Post-transcriptional control of MiRNA biogenesis. RNA. 2019;25:1\u201316. https:\/\/doi.org\/10.1261\/rna.068692.118.","journal-title":"RNA"},{"key":"6810_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12929-023-00964-w","volume":"30","author":"HM Nail","year":"2023","unstructured":"Nail HM, Chiu CC, Leung CH, Ahmed MMM, Wang HD. Exosomal miRNA-mediated intercellular communications and Immunomodulatory effects in tumor microenvironments. J Biomed Sci. 2023;30:69. https:\/\/doi.org\/10.1186\/s12929-023-00964-w.","journal-title":"J Biomed Sci"},{"key":"6810_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1134\/S0006297913060084","volume":"78","author":"P Pashkovskiy","year":"2013","unstructured":"Pashkovskiy P, Ryazansky S. Biogenesis, evolution, and functions of plant MicroRNAs. Biochem (Moscow). 2013;78:627\u201337.","journal-title":"Biochem (Moscow)"},{"key":"6810_CR27","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1177\/0300985813502820","volume":"51","author":"M Bhaskaran","year":"2014","unstructured":"Bhaskaran M, Mohan M. MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Vet Pathol. 2014;51:759\u201374.","journal-title":"Vet Pathol"},{"key":"6810_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1261\/rna.2183803","volume":"9","author":"V Ambros","year":"2003","unstructured":"Ambros V, et al. A uniform system for MicroRNA annotation. RNA. 2003;9:277\u20139. https:\/\/doi.org\/10.1261\/rna.2183803.","journal-title":"RNA"},{"key":"6810_CR29","doi-asserted-by":"publisher","first-page":"D152","DOI":"10.1093\/nar\/gkq1027","volume":"39","author":"A Kozomara","year":"2011","unstructured":"Kozomara A, Griffiths-Jones S. MiRBase: integrating MicroRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011;39:D152\u2013157. https:\/\/doi.org\/10.1093\/nar\/gkq1027.","journal-title":"Nucleic Acids Res"},{"key":"6810_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018;9:402. https:\/\/doi.org\/10.3389\/fendo.2018.00402.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6810_CR31","doi-asserted-by":"publisher","first-page":"73271","DOI":"10.18632\/oncotarget.19154","volume":"8","author":"D Rong","year":"2017","unstructured":"Rong D, et al. An emerging function of circRNA-miRNAs-mRNA axis in human diseases. Oncotarget. 2017;8:73271\u201381. https:\/\/doi.org\/10.18632\/oncotarget.19154.","journal-title":"Oncotarget"},{"key":"6810_CR32","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1002\/1873-3468.12294","volume":"590","author":"D Hasler","year":"2016","unstructured":"Hasler D, Meister G. From tRNA to mirna: RNA-folding contributes to correct entry into noncoding RNA pathways. FEBS Lett. 2016;590:2354\u201363. https:\/\/doi.org\/10.1002\/1873-3468.12294.","journal-title":"FEBS Lett"},{"key":"6810_CR33","doi-asserted-by":"publisher","first-page":"e1003583","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18:e1003583. https:\/\/doi.org\/10.1371\/journal.pmed.1003583.","journal-title":"PLoS Med"},{"key":"6810_CR34","doi-asserted-by":"publisher","first-page":"e2436","DOI":"10.1371\/journal.pone.0002436","volume":"3","author":"N Dahiya","year":"2008","unstructured":"Dahiya N, et al. MicroRNA expression and identification of putative MiRNA targets in ovarian cancer. PLoS ONE. 2008;3:e2436. https:\/\/doi.org\/10.1371\/journal.pone.0002436.","journal-title":"PLoS ONE"},{"key":"6810_CR35","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.1182\/blood-2008-09-179168","volume":"113","author":"AJ O\u2019Hara","year":"2009","unstructured":"O\u2019Hara AJ, et al. Tumor suppressor MicroRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma. Blood. 2009;113:5938\u201341. https:\/\/doi.org\/10.1182\/blood-2008-09-179168.","journal-title":"Blood"},{"key":"6810_CR36","doi-asserted-by":"publisher","first-page":"13913","DOI":"10.1111\/jcmm.15989","volume":"24","author":"H Xie","year":"2020","unstructured":"Xie H, et al. Low let-7d exosomes from pulmonary vascular endothelial cells drive lung pericyte fibrosis through the TGF\u03b2RI\/FoxM1\/Smad\/\u03b2\u2010catenin pathway. J Cell Mol Med. 2020;24:13913\u201326.","journal-title":"J Cell Mol Med"},{"key":"6810_CR37","doi-asserted-by":"publisher","unstructured":"Sun L, et al. Exosomal MiRNA Let-7 from menstrual Blood-Derived endometrial stem cells alleviates pulmonary fibrosis through regulating mitochondrial DNA damage. Oxidative Med Cell Longev. 2019;2019. https:\/\/doi.org\/10.1155\/2019\/4506303.","DOI":"10.1155\/2019\/4506303"},{"key":"6810_CR38","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.2147\/ijn.S299969","volume":"16","author":"J Jin","year":"2021","unstructured":"Jin J, et al. Mesenchymal stem cells attenuate renal fibrosis via exosomes-mediated delivery of Microrna let-7i-5p Antagomir. Int J Nanomed. 2021;16:3565\u201378. https:\/\/doi.org\/10.2147\/ijn.S299969.","journal-title":"Int J Nanomed"},{"key":"6810_CR39","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3892\/ol.2011.413","volume":"2","author":"J Gao","year":"2011","unstructured":"Gao J, Liu QG. The role of miR-26 in tumors and normal tissues (Review). Oncol Lett. 2011;2:1019\u201323. https:\/\/doi.org\/10.3892\/ol.2011.413.","journal-title":"Oncol Lett"},{"key":"6810_CR40","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1101\/gad.1777409","volume":"23","author":"JT Huse","year":"2009","unstructured":"Huse JT, et al. The PTEN-regulating MicroRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 2009;23:1327\u201337. https:\/\/doi.org\/10.1101\/gad.1777409.","journal-title":"Genes Dev"},{"key":"6810_CR41","doi-asserted-by":"publisher","unstructured":"Zhao J, et al. MiR-26a-5p from HucMSC-derived extracellular vesicles inhibits epithelial mesenchymal transition by targeting Adam17 in silica-induced lung fibrosis. Ecotoxicol Environ Saf. 2023;257. https:\/\/doi.org\/10.1016\/j.ecoenv.2023.114950.","DOI":"10.1016\/j.ecoenv.2023.114950"},{"key":"6810_CR42","doi-asserted-by":"publisher","unstructured":"Zheng H, Ji J, Zhao T, Wang E, Zhang A. Exosome-encapsulated miR-26a attenuates aldosterone-induced tubulointerstitial fibrosis by inhibiting the CTGF\/SMAD3 signaling pathway. Int J Mol Med. 2023;51. https:\/\/doi.org\/10.3892\/ijmm.2022.5214.","DOI":"10.3892\/ijmm.2022.5214"},{"key":"6810_CR43","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/00002281-200211000-00009","volume":"14","author":"H Ihn","year":"2002","unstructured":"Ihn H. Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr Opin Rheumatol. 2002;14:681\u20135. https:\/\/doi.org\/10.1097\/00002281-200211000-00009.","journal-title":"Curr Opin Rheumatol"},{"key":"6810_CR44","doi-asserted-by":"publisher","unstructured":"Lipson KE, Wong C, Teng Y, Spong S. CTGF is a central mediator of tissue remodeling and fibrosis and its Inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair. 2012;5. https:\/\/doi.org\/10.1186\/1755-1536-5-S1-S24.","DOI":"10.1186\/1755-1536-5-S1-S24"},{"key":"6810_CR45","doi-asserted-by":"publisher","first-page":"13590","DOI":"10.1096\/fj.201900884R","volume":"33","author":"A Zhang","year":"2019","unstructured":"Zhang A, et al. Exogenous miR-26a suppresses muscle wasting and renal fibrosis in obstructive kidney disease. FASEB J. 2019;33:13590\u2013601. https:\/\/doi.org\/10.1096\/fj.201900884R.","journal-title":"FASEB J"},{"key":"6810_CR46","doi-asserted-by":"publisher","first-page":"8613","DOI":"10.1002\/jcp.29706","volume":"235","author":"X Wan","year":"2020","unstructured":"Wan X, et al. Mesenchymal stem cell-derived extracellular vesicles suppress the fibroblast proliferation by downregulating FZD6 expression in fibroblasts via micrRNA-29b-3p in idiopathic pulmonary fibrosis. J Cell Physiol. 2020;235:8613\u201325. https:\/\/doi.org\/10.1002\/jcp.29706.","journal-title":"J Cell Physiol"},{"key":"6810_CR47","doi-asserted-by":"publisher","unstructured":"Kholia S, et al. Human liver stem cell derived extracellular vesicles alleviate kidney fibrosis by interfering with the \u03b2-catenin pathway through mir29b. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms221910780.","DOI":"10.3390\/ijms221910780"},{"key":"6810_CR48","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s12012-022-09745-7","volume":"22","author":"J Zheng","year":"2022","unstructured":"Zheng J, et al. Bone marrow mesenchymal stem Cell-Derived Exosomal microRNA-29b-3p promotes angiogenesis and ventricular remodeling in rats with myocardial infarction by targeting ADAMTS16. Cardiovasc Toxicol. 2022;22:689\u2013700. https:\/\/doi.org\/10.1007\/s12012-022-09745-7.","journal-title":"Cardiovasc Toxicol"},{"key":"6810_CR49","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ymthe.2019.01.008","volume":"27","author":"H Wang","year":"2019","unstructured":"Wang H, et al. Exosome-Mediated miR-29 transfer reduces muscle atrophy and kidney fibrosis in mice. Mol Ther. 2019;27:571\u201383. https:\/\/doi.org\/10.1016\/j.ymthe.2019.01.008.","journal-title":"Mol Ther"},{"key":"6810_CR50","doi-asserted-by":"publisher","unstructured":"Yuan R, Dai X, Li Y, Li C, Liu L. Exosomes from miR-29a-modified adipose-derived mesenchymal stem cells reduce excessive Scar formation by inhibiting TGF-\u03b22\/Smad3 signaling. Mol Med Rep. 2021;24. https:\/\/doi.org\/10.3892\/mmr.2021.12398.","DOI":"10.3892\/mmr.2021.12398"},{"key":"6810_CR51","doi-asserted-by":"publisher","first-page":"e2202959","DOI":"10.1002\/adhm.202202959","volume":"12","author":"J Yuan","year":"2023","unstructured":"Yuan J, et al. Microneedle patch loaded with exosomes containing MicroRNA-29b prevents cardiac fibrosis after myocardial infarction. Adv Healthc Mater. 2023;12:e2202959. https:\/\/doi.org\/10.1002\/adhm.202202959.","journal-title":"Adv Healthc Mater"},{"key":"6810_CR52","doi-asserted-by":"publisher","unstructured":"Cai P, et al. Serum Exosomal MiRNAs for grading hepatic fibrosis due to schistosomiasis. Int J Mol Sci. 2020;21. https:\/\/doi.org\/10.3390\/ijms21103560.","DOI":"10.3390\/ijms21103560"},{"key":"6810_CR53","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1002\/jcb.27731","volume":"120","author":"J Pan","year":"2019","unstructured":"Pan J, Alimujiang M, Chen Q, Shi H, Luo X. Exosomes derived from miR-146a-modified adipose-derived stem cells attenuate acute myocardial infarction-induced myocardial damage via downregulation of early growth response factor 1. J Cell Biochem. 2019;120:4433\u201343. https:\/\/doi.org\/10.1002\/jcb.27731.","journal-title":"J Cell Biochem"},{"key":"6810_CR54","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/cvr\/cvz108","volume":"116","author":"G Milano","year":"2020","unstructured":"Milano G, et al. Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin\/trastuzumab-induced cardiac toxicity. Cardiovasc Res. 2020;116:383\u201392. https:\/\/doi.org\/10.1093\/cvr\/cvz108.","journal-title":"Cardiovasc Res"},{"key":"6810_CR55","doi-asserted-by":"publisher","first-page":"23243","DOI":"10.1002\/jcp.28891","volume":"234","author":"YC Liang","year":"2019","unstructured":"Liang YC, et al. TNF-\u03b1-induced Exosomal miR-146a mediates mesenchymal stem cell-dependent suppression of urethral stricture. J Cell Physiol. 2019;234:23243\u201355. https:\/\/doi.org\/10.1002\/jcp.28891.","journal-title":"J Cell Physiol"},{"key":"6810_CR56","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1476-4598-12-43","volume":"12","author":"Y Chen","year":"2013","unstructured":"Chen Y, Song YX, Wang ZN. The microRNA-148\/152 family: multi-faceted players. Mol Cancer. 2013;12:43. https:\/\/doi.org\/10.1186\/1476-4598-12-43.","journal-title":"Mol Cancer"},{"key":"6810_CR57","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1002\/eji.201747132","volume":"47","author":"M Friedrich","year":"2017","unstructured":"Friedrich M, et al. The role of the miR-148\/\u2010152 family in physiology and disease. Eur J Immunol. 2017;47:2026\u201338.","journal-title":"Eur J Immunol"},{"key":"6810_CR58","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s12033-021-00441-5","volume":"64","author":"J Xuan","year":"2022","unstructured":"Xuan J, et al. Extracellular vesicles from miR-148a-5p-Enriched bone marrow mesenchymal stem cells relieve hepatic fibrosis by targeting Smad4. Mol Biotechnol. 2022;64:535\u201345. https:\/\/doi.org\/10.1007\/s12033-021-00441-5.","journal-title":"Mol Biotechnol"},{"key":"6810_CR59","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s13287-022-03010-y","volume":"13","author":"S Tian","year":"2022","unstructured":"Tian S, et al. Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6\/STAT3 pathway in macrophages. Stem Cell Res Ther. 2022;13:330. https:\/\/doi.org\/10.1186\/s13287-022-03010-y.","journal-title":"Stem Cell Res Ther"},{"key":"6810_CR60","doi-asserted-by":"publisher","unstructured":"Chen S, et al. Exosomal miR-152-5p\/ARHGAP6\/ROCK axis regulates apoptosis and fibrosis in cardiomyocytes. Experimental Therapeutic Med. 2023;25. https:\/\/doi.org\/10.3892\/etm.2023.11864.","DOI":"10.3892\/etm.2023.11864"},{"key":"6810_CR61","doi-asserted-by":"publisher","unstructured":"Amin MMJ, Trevelyan CJ, Turner NA. MicroRNA-214 in health and disease. Cells. 2021;10. https:\/\/doi.org\/10.3390\/cells10123274.","DOI":"10.3390\/cells10123274"},{"key":"6810_CR62","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/hep.26768","volume":"59","author":"L Chen","year":"2014","unstructured":"Chen L, et al. Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology. 2014;59:1118\u201329. https:\/\/doi.org\/10.1002\/hep.26768.","journal-title":"Hepatology"},{"key":"6810_CR63","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/molehr\/gay019","volume":"24","author":"D Wu","year":"2018","unstructured":"Wu D, Lu P, Mi X, Miao J. Exosomal miR-214 from endometrial stromal cells inhibits endometriosis fibrosis. Mol Hum Reprod. 2018;24:357\u201365. https:\/\/doi.org\/10.1093\/molehr\/gay019.","journal-title":"Mol Hum Reprod"},{"key":"6810_CR64","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s43032-020-00350-z","volume":"28","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, et al. Down-regulation of Exosomal miR-214-3p targeting CCN2 contributes to endometriosis fibrosis and the role of exosomes in the horizontal transfer of miR-214-3p. Reproductive Sci. 2021;28:715\u201327. https:\/\/doi.org\/10.1007\/s43032-020-00350-z.","journal-title":"Reproductive Sci"},{"key":"6810_CR65","doi-asserted-by":"publisher","first-page":"781815","DOI":"10.3389\/fimmu.2021.781815","volume":"12","author":"S Yuan","year":"2021","unstructured":"Yuan S, et al. miR-223: an immune regulator in infectious disorders. Front Immunol. 2021;12:781815. https:\/\/doi.org\/10.3389\/fimmu.2021.781815.","journal-title":"Front Immunol"},{"key":"6810_CR66","doi-asserted-by":"publisher","unstructured":"Hou L, et al. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles alleviated silica induced lung inflammation and fibrosis in mice via circPWWP2A\/miR-223\u20133p\/NLRP3 axis. Ecotoxicol Environ Saf. 2023;251. https:\/\/doi.org\/10.1016\/j.ecoenv.2023.114537.","DOI":"10.1016\/j.ecoenv.2023.114537"},{"key":"6810_CR67","doi-asserted-by":"publisher","unstructured":"Yang M, et al. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles loaded with miR-223 ameliorate myocardial infarction through P53\/S100A9 axis. Genomics. 2022;114. https:\/\/doi.org\/10.1016\/j.ygeno.2022.110319.","DOI":"10.1016\/j.ygeno.2022.110319"},{"key":"6810_CR68","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.31658","volume":"74","author":"X Hou","year":"2021","unstructured":"Hou X, et al. Myeloid-Cell\u2013Specific IL-6 signaling promotes MicroRNA-223-Enriched exosome production to attenuate NAFLD-Associated fibrosis. Hepatology. 2021;74:116\u201332. https:\/\/doi.org\/10.1002\/hep.31658.","journal-title":"Hepatology"},{"key":"6810_CR69","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3892\/br.2016.747","volume":"5","author":"YH Feng","year":"2016","unstructured":"Feng YH, Tsao CJ. Emerging role of microRNA-21 in cancer. Biomed Rep. 2016;5:395\u2013402. https:\/\/doi.org\/10.3892\/br.2016.747.","journal-title":"Biomed Rep"},{"key":"6810_CR70","doi-asserted-by":"publisher","unstructured":"Wang P, et al. miR-21 in EVs from pulmonary epithelial cells promotes myofibroblast differentiation via Glycolysis in arsenic-induced pulmonary fibrosis. Environ Pollut. 2021;286. https:\/\/doi.org\/10.1016\/j.envpol.2021.117259.","DOI":"10.1016\/j.envpol.2021.117259"},{"key":"6810_CR71","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.toxlet.2021.04.017","volume":"347","author":"J Bai","year":"2021","unstructured":"Bai J, et al. CircRNA_0026344 via Exosomal miR-21 regulation of Smad7 is involved in aberrant cross-talk of epithelium-fibroblasts during cigarette smoke-induced pulmonary fibrosis. Toxicol Lett. 2021;347:58\u201366. https:\/\/doi.org\/10.1016\/j.toxlet.2021.04.017.","journal-title":"Toxicol Lett"},{"key":"6810_CR72","doi-asserted-by":"publisher","unstructured":"Makiguchi T, et al. Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis. Respir Res. 2016;17. https:\/\/doi.org\/10.1186\/s12931-016-0427-3.","DOI":"10.1186\/s12931-016-0427-3"},{"key":"6810_CR73","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1136\/thoraxjnl-2020-215962","volume":"76","author":"S Sato","year":"2021","unstructured":"Sato S, et al. Fibrotic extracellular matrix induces release of extracellular vesicles with pro-fibrotic MiRNA from fibrocytes. Thorax. 2021;76:895\u2013906. https:\/\/doi.org\/10.1136\/thoraxjnl-2020-215962.","journal-title":"Thorax"},{"key":"6810_CR74","doi-asserted-by":"publisher","unstructured":"Liu JR, et al. Caloric restriction alleviates aging-related fibrosis of kidney through downregulation of miR-21 in extracellular vesicles. Aging. 2020;12. https:\/\/doi.org\/10.18632\/aging.103591.","DOI":"10.18632\/aging.103591"},{"key":"6810_CR75","doi-asserted-by":"publisher","first-page":"8660","DOI":"10.7150\/thno.62820","volume":"11","author":"S Zhao","year":"2021","unstructured":"Zhao S, et al. Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys. Theranostics. 2021;11:8660\u201373. https:\/\/doi.org\/10.7150\/thno.62820.","journal-title":"Theranostics"},{"key":"6810_CR76","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41419-022-05305-7","volume":"13","author":"S Xu","year":"2022","unstructured":"Xu S, et al. Bone marrow mesenchymal stem cell-derived Exosomal miR-21a-5p alleviates renal fibrosis by attenuating Glycolysis by targeting PFKM. Cell Death Dis. 2022;13:876. https:\/\/doi.org\/10.1038\/s41419-022-05305-7.","journal-title":"Cell Death Dis"},{"key":"6810_CR77","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.spinee.2023.05.007","volume":"23","author":"V Ganesh","year":"2023","unstructured":"Ganesh V, et al. Pharmacotherapies to prevent epidural fibrosis after laminectomy: a systematic review of in vitro and in vivo animal models. Spine J. 2023;23:1471\u201384. https:\/\/doi.org\/10.1016\/j.spinee.2023.05.007.","journal-title":"Spine J"},{"key":"6810_CR78","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/jir.S254879","volume":"13","author":"Z Yao","year":"2020","unstructured":"Yao Z, et al. Microrna-21-3p engineered umbilical cord stem cell-derived exosomes inhibit tendon adhesion. J Inflamm Res. 2020;13:303\u201316. https:\/\/doi.org\/10.2147\/jir.S254879.","journal-title":"J Inflamm Res"},{"key":"6810_CR79","doi-asserted-by":"publisher","unstructured":"Li Y, et al. Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic Scar fibrosis by miR-192-5p\/IL-17RA\/Smad axis. Stem Cell Res Therapy. 2021;12. https:\/\/doi.org\/10.1186\/s13287-021-02290-0.","DOI":"10.1186\/s13287-021-02290-0"},{"key":"6810_CR80","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/jcmm.16119","volume":"25","author":"Z Du","year":"2021","unstructured":"Du Z, Wu T, Liu L, Luo B, Wei C. Extracellular vesicles-derived miR-150-5p secreted by adipose-derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis. J Cell Mol Med. 2021;25:701\u201315. https:\/\/doi.org\/10.1111\/jcmm.16119.","journal-title":"J Cell Mol Med"},{"key":"6810_CR81","doi-asserted-by":"publisher","unstructured":"Wang SJ, et al. Bone marrow mesenchymal stem cell-derived extracellular vesicles containing miR-181d protect rats against renal fibrosis by inhibiting KLF6 and the NF-\u03baB signaling pathway. Cell Death Dis. 2022;13. https:\/\/doi.org\/10.1038\/s41419-022-04875-w.","DOI":"10.1038\/s41419-022-04875-w"},{"key":"6810_CR82","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1111\/jcmm.13208","volume":"21","author":"G Lou","year":"2017","unstructured":"Lou G, et al. MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis. J Cell Mol Med. 2017;21:2963\u201373. https:\/\/doi.org\/10.1111\/jcmm.13208.","journal-title":"J Cell Mol Med"},{"key":"6810_CR83","doi-asserted-by":"publisher","unstructured":"Li D et al. Mesenchymal Stem Cells Alleviate Renal Fibrosis and Inhibit Autophagy via Exosome Transfer of miRNA-122a. Stem Cells Int 2022, 1981798 (2022). https:\/\/doi.org\/10.1155\/2022\/1981798","DOI":"10.1155\/2022\/1981798"},{"key":"6810_CR84","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1111\/jcmm.13170","volume":"21","author":"Y Qu","year":"2017","unstructured":"Qu Y, et al. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation. J Cell Mol Med. 2017;21:2491\u2013502. https:\/\/doi.org\/10.1111\/jcmm.13170.","journal-title":"J Cell Mol Med"},{"key":"6810_CR85","doi-asserted-by":"publisher","unstructured":"Vaskova E, et al. Sacubitril\/valsartan improves cardiac function and decreases myocardial fibrosis via downregulation of Exosomal mir-181a in a rodent chronic myocardial infarction model. J Am Heart Association. 2020;9. https:\/\/doi.org\/10.1161\/jaha.119.015640.","DOI":"10.1161\/jaha.119.015640"},{"key":"6810_CR86","doi-asserted-by":"publisher","unstructured":"Guan H, et al. Injured tubular epithelial cells activate fibroblasts to promote kidney fibrosis through miR-150-containing exosomes. Exp Cell Res. 2020;392. https:\/\/doi.org\/10.1016\/j.yexcr.2020.112007.","DOI":"10.1016\/j.yexcr.2020.112007"},{"key":"6810_CR87","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.7150\/ijbs.62478","volume":"17","author":"X Zhou","year":"2021","unstructured":"Zhou X, et al. Tubular cell-derived Exosomal miR-150-5p contributes to renal fibrosis following unilateral ischemia-reperfusion injury by activating fibroblast in vitro and in vivo. Int J Biol Sci. 2021;17:4021\u201333. https:\/\/doi.org\/10.7150\/ijbs.62478.","journal-title":"Int J Biol Sci"},{"key":"6810_CR88","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1038\/s41598-017-03389-2","volume":"7","author":"YS Lee","year":"2017","unstructured":"Lee YS, et al. Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells. Sci Rep. 2017;7:3710. https:\/\/doi.org\/10.1038\/s41598-017-03389-2.","journal-title":"Sci Rep"},{"key":"6810_CR89","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/hep.31050","volume":"72","author":"XL Liu","year":"2020","unstructured":"Liu XL, et al. Lipotoxic Hepatocyte-Derived Exosomal MicroRNA 192-5p activates macrophages through rictor\/akt\/forkhead box transcription factor O1 signaling in nonalcoholic fatty liver disease. Hepatology. 2020;72:454\u201369. https:\/\/doi.org\/10.1002\/hep.31050.","journal-title":"Hepatology"},{"key":"6810_CR90","doi-asserted-by":"publisher","first-page":"109899","DOI":"10.1016\/j.cbi.2022.109899","volume":"358","author":"Z Dong","year":"2022","unstructured":"Dong Z, et al. Exosomal miR-181a-2-3p derived from citreoviridin-treated hepatocytes activates hepatic stellate cells trough inducing mitochondrial calcium overload. Chem Biol Interact. 2022;358:109899. https:\/\/doi.org\/10.1016\/j.cbi.2022.109899.","journal-title":"Chem Biol Interact"},{"key":"6810_CR91","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, et al. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43. https:\/\/doi.org\/10.1186\/1471-2288-14-43.","journal-title":"BMC Med Res Methodol"},{"key":"6810_CR92","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jconrel.2015.08.039","volume":"219","author":"KA Ross","year":"2015","unstructured":"Ross KA, et al. Nano-enabled delivery of diverse payloads across complex biological barriers. J Control Release. 2015;219:548\u201359. https:\/\/doi.org\/10.1016\/j.jconrel.2015.08.039.","journal-title":"J Control Release"},{"key":"6810_CR93","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jconrel.2024.10.014","volume":"376","author":"D Tarab-Ravski","year":"2024","unstructured":"Tarab-Ravski D, et al. The future of genetic medicines delivered via targeted lipid nanoparticles to leukocytes. J Control Release. 2024;376:286\u2013302. https:\/\/doi.org\/10.1016\/j.jconrel.2024.10.014.","journal-title":"J Control Release"},{"key":"6810_CR94","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1002\/hep.30542","volume":"69","author":"K McDaniel","year":"2019","unstructured":"McDaniel K, et al. Amelioration of ductular reaction by stem cell derived extracellular vesicles in MDR2 knockout mice via Lethal-7 MicroRNA. Hepatology. 2019;69:2562\u201378. https:\/\/doi.org\/10.1002\/hep.30542.","journal-title":"Hepatology"},{"key":"6810_CR95","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/mt.2016.90","volume":"24","author":"B Wang","year":"2016","unstructured":"Wang B, et al. Mesenchymal stem cells deliver exogenous MicroRNA-let7c via exosomes to attenuate renal fibrosis. Mol Ther. 2016;24:1290\u2013301. https:\/\/doi.org\/10.1038\/mt.2016.90.","journal-title":"Mol Ther"},{"key":"6810_CR96","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.7150\/thno.29579","volume":"9","author":"B Wang","year":"2019","unstructured":"Wang B, et al. miR-26a limits muscle wasting and cardiac fibrosis through exosome-mediated MicroRNA transfer in chronic kidney disease. Theranostics. 2019;9:1864\u201377. https:\/\/doi.org\/10.7150\/thno.29579.","journal-title":"Theranostics"},{"key":"6810_CR97","doi-asserted-by":"publisher","first-page":"414","DOI":"10.15283\/ijsc20049","volume":"13","author":"Q Tan","year":"2020","unstructured":"Tan Q, Xia D, Ying X. miR-29a in exosomes from bone marrow mesenchymal stem cells inhibit fibrosis during endometrial repair of intrauterine adhesion. Int J Stem Cells. 2020;13:414\u201323. https:\/\/doi.org\/10.15283\/ijsc20049.","journal-title":"Int J Stem Cells"},{"key":"6810_CR98","doi-asserted-by":"publisher","unstructured":"Song J, et al. Exosomal MiRNAs contribute to coal dust particle-induced pulmonary fibrosis in rats. Ecotoxicol Environ Saf. 2023;249. https:\/\/doi.org\/10.1016\/j.ecoenv.2022.114454.","DOI":"10.1016\/j.ecoenv.2022.114454"},{"key":"6810_CR99","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.3892\/ijmm.2019.4150","volume":"43","author":"JY Kang","year":"2019","unstructured":"Kang JY, et al. Human peripheral blood\u2013derived exosomes for MicroRNA delivery. Int J Mol Med. 2019;43:2319\u201328. https:\/\/doi.org\/10.3892\/ijmm.2019.4150.","journal-title":"Int J Mol Med"},{"key":"6810_CR100","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1172\/jci70577","volume":"124","author":"C Bang","year":"2014","unstructured":"Bang C, et al. Cardiac fibroblast-derived MicroRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest. 2014;124:2136\u201346. https:\/\/doi.org\/10.1172\/jci70577.","journal-title":"J Clin Invest"},{"key":"6810_CR101","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12079-014-0220-3","volume":"8","author":"A Charrier","year":"2014","unstructured":"Charrier A, et al. Connective tissue growth factor (CCN2) and microRNA-21 are components of a positive feedback loop in pancreatic stellate cells (PSC) during chronic pancreatitis and are exported in PSC-derived exosomes. J Cell Communication Signal. 2014;8:147\u201356. https:\/\/doi.org\/10.1007\/s12079-014-0220-3.","journal-title":"J Cell Communication Signal"},{"key":"6810_CR102","doi-asserted-by":"publisher","unstructured":"Broermann A, et al. Exosomal MiRNAs as potential biomarkers to monitor phosphodiesterase 5 inhibitor induced Anti-Fibrotic effects on CCl(4) treated rats. Int J Mol Sci. 2020;22. https:\/\/doi.org\/10.3390\/ijms22010382.","DOI":"10.3390\/ijms22010382"},{"key":"6810_CR103","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.omtn.2019.01.006","volume":"14","author":"JH Kim","year":"2019","unstructured":"Kim JH, Lee CH, Lee SW. Exosomal transmission of MicroRNA from HCV replicating cells stimulates transdifferentiation in hepatic stellate cells. Mol Therapy - Nucleic Acids. 2019;14:483\u201397. https:\/\/doi.org\/10.1016\/j.omtn.2019.01.006.","journal-title":"Mol Therapy - Nucleic Acids"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06810-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06810-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06810-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:12:50Z","timestamp":1757250770000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06810-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6810"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06810-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"802"}}